The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Na minha lista:
| Principais autores: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2011-12-01
|
| 叢編: | Oncology Reviews |
| 主題: | |
| 在線閱讀: | http://oncologyreviews.org/index.php/or/article/view/157 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|